KCNH2 and skin sensitization: Based on the predicted results of ADMET properties, comparison to lovastatin, CA showed better performance in ADMET toxicological properties, such as hERG (hERG blockers), H-HT (human hepatotoxicity), SkinSen (skin sensitization), FDAMDD (FDA maximum daily dose), and respiratory toxicity.